Phase 1 pharmacokinetic and drug-interaction study of dasatinib in patients with advanced solid tumors

Cancer
Faye M JohnsonAlberto Chiappori

Abstract

The recently developed the Src and Abelson (Abl) kinase inhibitor dasatinib has antitumor effects in epithelial and mesenchymal tumors. Preclinical data have indicated that dasatinib is metabolized primarily through cytochrome P450 3A4 (CYP3A4) and may cause QT prolongation. In light of its improved tolerability, the authors were interested in the safety of a once-daily dasatinib regimen. The authors conducted a phase 1 trial of dasatinib in 29 patients with advanced solid tumors. Segment 1 of the trial was short term and sequential and was designed to determine whether the coadministration of the potent CYP3A4 inhibitor ketoconazole had an effect on the pharmacokinetics of dasatinib. Segment 2 was designed to evaluate the safety of dasatinib as dosing was increased. QT intervals were monitored closely in both segments. Efficacy was assessed in Segment 2 using both positron emission tomography and computed tomography. Hematologic toxicities were markedly less than those observed in patients with leukemia, whereas nonhematologic toxicities were similar. The authors determined that the maximum recommended dose was 180 mg once daily based on the incidence of pleural effusion. Coadministration of ketoconazole led to a marked increa...Continue Reading

References

Jan 1, 1993·The Journal of Clinical Investigation·M S TalamontiG E Gallick
Feb 16, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H YoungP Price
Nov 6, 2003·Toxicological Sciences : an Official Journal of the Society of Toxicology·Robert L HamlinDavid M Hamlin
Dec 9, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maksim V YezhelyevChristiane J Bruns
Oct 6, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Faye M JohnsonNicholas J Donato
Jun 16, 2006·The New England Journal of Medicine·Moshe TalpazCharles L Sawyers
Jun 30, 2007·American Journal of Respiratory and Critical Care Medicine·Anne BergeronPhilippe Rousselot
Sep 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alfonso Quintás-CardamaJorge Cortes
Nov 30, 2007·Anti-cancer Agents in Medicinal Chemistry·Faye M Johnson, Gary E Gallick
Jun 11, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neil P ShahAndreas Hochhaus
Nov 18, 2008·Molecular Cancer Research : MCR·Ralf BuettnerRichard Jove

❮ Previous
Next ❯

Citations

May 3, 2013·Cancer Chemotherapy and Pharmacology·Antoinette R TanJoseph J Stephenson
Mar 13, 2012·Journal of Neuro-oncology·David A ReardonHenry S Friedman
Dec 17, 2010·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Mark P S DunphySteven Larson
Dec 24, 2010·Journal of Virology·Elena E GorbunovaErich R Mackow
Jul 28, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Angeles Alvarez SecordRobert M Wenham
Apr 28, 2011·The Oncologist·Lauren N PulsWells Messersmith
Jul 12, 2011·The Oncologist·Ishwaria M SubbiahApostolia M Tsimberidou
Jul 8, 2011·Future Oncology·Katayoon Kasaian, Steven Jm Jones
Apr 16, 2014·Current Treatment Options in Cardiovascular Medicine·Peter Y Kim, Michael S Ewer
Apr 16, 2014·Proceedings of the National Academy of Sciences of the United States of America·M Imran AslamCharles Keller
Oct 29, 2010·Medizinische Klinik·Wolfram Dempke, Roland Zippel
Jun 15, 2011·Expert Review of Hematology·Amber FullmerElias Jabbour
Apr 17, 2013·Expert Opinion on Drug Safety·Esther CarceleroNatalia Creus
Aug 6, 2010·Expert Opinion on Drug Metabolism & Toxicology·Derek R Duckett, Michael D Cameron
Jan 31, 2015·Drug Development and Industrial Pharmacy·Yunfang ZhouJianshe Ma
Jun 19, 2010·Expert Opinion on Emerging Drugs·Christopher Fung, Jennifer R Grandis
Jun 19, 2010·Expert Opinion on Investigational Drugs·Silvia SchenoneMaurizio Botta
Oct 14, 2014·Journal of Pharmaceutical Sciences·Jie ShaoGuohua An
May 31, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Melissa L JohnsonVincent A Miller
Sep 14, 2010·Cancer Treatment Reviews·Heinz-Josef KlümpenHoward Gurney
May 17, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Yasuhiro TsumeGordon L Amidon
Jul 26, 2011·Cancer Science·Shunji TakahashiKiyohiko Hatake
Jun 27, 2013·Journal of Clinical Pharmacology·Narayana I NarasimhanDaryl Sonnichsen
Jun 5, 2013·International Journal of Cancer. Journal International Du Cancer·Antonios N GargalionisAthanasios G Papavassiliou
Apr 9, 2016·International Journal of Molecular Sciences·Atik Badshah ShaikhGe Zhang
Jul 6, 2014·The Lancet Oncology·Roelof W F van LeeuwenFrank G A Jansman
Mar 31, 2015·Cancer Treatment Reviews·Maikel HerbrinkJos H Beijnen
Jan 11, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jessica M van der BolRon H J Mathijssen
Feb 2, 2015·Critical Reviews in Oncology/hematology·Florence RanchonBenoit You
Sep 15, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marc PocardDominique Bellet
Sep 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Faye M JohnsonDavid J Stewart
Mar 23, 2017·Expert Review of Anti-infective Therapy·Juan AmbrosioniJosé M Miró
Apr 8, 2017·Expert Opinion on Drug Safety·Mayte CoirasJosé Alcamí
Mar 15, 2013·Therapeutic Advances in Cardiovascular Disease·Saurabh AggarwalRohit Arora

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
A Olivieri, L Manzione
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Eric B HauraGerold Bepler
© 2021 Meta ULC. All rights reserved